Ranbaxy net dips by 8% - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Ranbaxy net dips by 8%

Jan 15, 2001

Ranbaxy has reported a net profit of Rs 1,809 m on a turnover of Rs 17,418 m for the full year ended December 2000. While turnover has grown 12% the net profit has actually declined by 8%. However, for the fourth quarter ended 30th December 2000, net profit has gone up by 50% to Rs 483 m. Sales for the fourth quarter has increased from Rs 4,168 m to Rs 4,785 m.

(Rs m) FY00 FY01 Change
Sales 15,598 17,418 11.7%
Other Income 715 471 -34.1%
Profit after Tax/(Loss) 1,969 1,809 -8.1%
Net profit margin (%) 12.6% 10.4%  
No. of Shares (eoy) (m) 115.9 115.9  
Earnings per share 17.0 15.6  
P/E   41.4  

The disappointment for Ranbaxy, however, was the non-receipt of the milestone payment from Bayer, which the company has said will accrue in the first quarter of the current year. Besides, the company’s export of the generic cefuroxime axcetil has also run aground due to the litigation filed by Glaxo in the US courts. The coming year’s performance would be dependent on how soon the company’s US subsidiary breaks even.

The stock quotes at a price of Rs 646 which implies an earnings multiple of 41 times. The year 2000 saw the stock come off almost 50%. Whether 2001 would be any better remains to be seen.

Equitymaster requests your view! Post a comment on "Ranbaxy net dips by 8%". Click here!


More Views on News

Sorry! There are no related views on news for this company/sector.

Most Popular

My Top Stock to Buy in this Market Selloff (Profit Hunter)

Sep 22, 2020

The recent correction offers a great opportunity to buy this high conviction smallcap stock.

Can the Nifty Fall to 10,200? (Fast Profits Daily)

Sep 24, 2020

The Nifty has reached an important support level today. If it breaks then we could see further downside.

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...

I Believe These Stocks Will Deliver the Most Outsized Returns in 2021 and Beyond (Profit Hunter)

Sep 23, 2020

Rules of the racetrack can help you bag the biggest gainers of the coming decade.


Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms


Apr 1, 2015 (Close)


  • Track your investment in RANBAXY LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks